Weaver C. Barksdale & Associates’s HNI Corp HNI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$14K Buy
351
+54
+18% +$1.98K 0.01% 215
2017
Q3
$12K Buy
297
+13
+5% +$489 0.01% 234
2017
Q2
$11K Buy
284
+28
+11% +$1.22K 0.01% 249
2017
Q1
$12K Buy
256
+20
+8% +$963 0.01% 242
2016
Q4
$13K Buy
236
+29
+14% +$1.37K 0.02% 223
2016
Q3
$8K Sell
207
-12
-5% -$608 0.01% 300
2016
Q2
$10K Sell
219
-59
-21% -$2.59K 0.02% 237
2016
Q1
$11K Buy
278
+24
+9% +$816 0.01% 247
2015
Q4
$9K Buy
254
+30
+13% +$1.27K 0.01% 275
2015
Q3
$10K Buy
224
+24
+12% +$1.14K 0.01% 257
2015
Q2
$10K Buy
200
+17
+9% +$877 0.01% 279
2015
Q1
$10K Hold
183
0.01% 280
2014
Q4
$9K Sell
183
-55
-23% -$2.48K 0.01% 284
2014
Q3
$9K Buy
238
+5
+2% +$188 0.01% 280
2014
Q2
$9K Sell
233
-22
-9% -$804 0.01% 286
2014
Q1
$9K Buy
255
+26
+11% +$929 0.01% 279
2013
Q4
$9K Hold
229
0.01% 294
2013
Q3
$8K Buy
229
+7
+3% +$258 0.01% 303
2013
Q2
$8K Buy
+222
New +$7.78K 0.01% 301

Other funds holding HNI

Weaver C. Barksdale & Associates's HNI Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its HNI Corp (HNI) stake by 18% in Q4 2017, buying an estimated $1.98K and bringing the position to 351 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #215.

Weaver C. Barksdale & Associates first reported a position in HNI in Q2 2013 and has held it in 19 quarters since. 176 funds tracked by Wall St. Rank hold HNI as of Q4 2017.

  • Weaver C. Barksdale & Associates held 351 shares of HNI Corp worth $14K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 54 HNI Corp shares in Q4 2017, an estimated $1.98K.
  • HNI Corp made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #215 holding.
  • Weaver C. Barksdale & Associates first reported a position in HNI Corp in Q2 2013 and has held it in 19 quarters since.
  • 176 funds tracked by Wall St. Rank held HNI Corp as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.